PTC Therapeutics, Inc. (PTCT)
72.43
+0.73
(+1.02%)
USD |
NASDAQ |
Apr 17, 16:00
72.41
-0.02
(-0.03%)
After-Hours: 20:00
PTC Therapeutics SG&A Expense (Quarterly) : 96.87M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insmed, Inc. | 212.48M |
| Sarepta Therapeutics, Inc. | 128.30M |
| Keros Therapeutics, Inc. | 11.74M |
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| Protagonist Therapeutics, Inc. | 11.43M |